XNAS
STSS
Market cap4mUSD
May 20, Last price
4.10USD
1D
-4.21%
1Q
1,043.02%
IPO
136.99%
Name
Sharps Technology Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-32.81%
Rev. gr., 5y
%
Revenues
0k
Net income
-9m
L-5.54%
CFO
-7m
L-18.55%
Profile
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | 9,627 | 11,018 | 9,393 | |||
Unusual Expense (Income) | ||||||
NOPBT | (9,627) | (11,018) | (9,393) | |||
NOPBT Margin | ||||||
Operating Taxes | (30) | (30) | (5,420) | |||
Tax Rate | ||||||
NOPAT | (9,597) | (10,988) | (3,974) | |||
Net income | (9,296) -5.54% | (9,842) -1,361.93% | 780 -116.14% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 8,030 | 14,267 | ||||
BB yield | -148.14% | -145.56% | ||||
| Debt | ||||||
Debt current | 3,764 | |||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | 2,900 | (3,013) | (4,171) | |||
| Cash flow | ||||||
Cash from operating activities | (6,930) | (8,507) | (6,433) | |||
CAPEX | (139) | (698) | (752) | |||
Cash from investing activities | (1,163) | (698) | (3,118) | |||
Cash from financing activities | 5,907 | 8,030 | 12,235 | |||
FCF | (7,698) | (10,469) | (8,009) | |||
| Balance | ||||||
Cash | 864 | 3,013 | 4,171 | |||
Long term investments | ||||||
Excess cash | 864 | 3,013 | 4,171 | |||
Stockholders' equity | (34,422) | (24,556) | (15,092) | |||
Invested Capital | 40,181 | 32,490 | 24,733 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 1,256 | 13,033 | 8,100 | |||
Price | 2.06 395.31% | 0.42 -65.63% | 1.21 | |||
Market cap | 2,588 -52.26% | 5,420 -44.70% | 9,801 | |||
EV | 5,487 | 2,407 | 5,631 | |||
EBITDA | (8,853) | (10,136) | (8,739) | |||
EV/EBITDA | ||||||
Interest | 1,665 | 138 | 1,320 | |||
Interest/NOPBT | ||||||